SAR443820
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SAR443820, covering 2025-01-03 to 2025-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis [Phase 2]